Carastock.

Cara Therapeutics' current financial performance and market outlook do not paint an encouraging picture for investors. Find out why CARA stock is a Sell.Cara Therapeutics, Inc. Common Stock. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is ...finance.yahoo.com - November 14 at 5:00 PM. Cara Therapeutics Stock (NASDAQ:CARA) Earnings Dates and Earning Calls. benzinga.com - November 14 at 7:53 AM. Cara Therapeutics GAAP EPS of -$0.52 beats by $0.01, revenue of $4.87M misses by $5.08M. msn.com - November 13 at 8:53 PM.Cara Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in the discovery, development, and commercialization of novel therapeutics to treat serious medical conditions, including pruritus.

12 thg 2, 2014 ... Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, ...Analyst Forecast. According to 8 analysts, the average rating for CARA stock is "Strong Buy." The 12-month stock price forecast is $15.13, which is an increase of 1,472.28% from the latest price.

Cara Therapeutics, Inc. (CARA) stock forecast and price target Find the latest Cara Therapeutics, Inc. CARA analyst stock forecast, price target, and recommendation trends with in-depth analysis ...

Cara Therapeutics Inc (CARA) stock is higher by 5.42% while the S&P 500 is lower by -0.08% as of 1:37 PM on Thursday, Apr 7. CARA has risen $0.69 from the previous closing price of $12.73 on volume of 256,141 shares. Over the past year the S&P 500 is higher by 9.75% while CARA is lower by -49.42%.Cara Therapeutics Inc (CARA) stock is trading at $5.05 as of 2:41 PM on Friday, Mar 31, an increase of $0.16, or 3.27% from the previous closing price of $4.89. The stock has traded between $4.90 and $5.06 so far today. Volume today is light. So far 469,000 shares have traded compared to average volume of 834,454 shares.Complete Cara Therapeutics Inc. stock information by Barron's. View real-time CARA stock price and news, along with industry-best analysis. Cara Therapeutics (CARA) Company Description. Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic ...

Get the latest Cara Therapeutics, Inc. (CARA) stock news and headlines to help you in your trading and investing decisions.

Find the latest analyst research for Cara Therapeutics, Inc. Common Stock (CARA) at Nasdaq.com.

Get the latest news and real-time alerts from Cara Therapeutics, Inc. (CARA) stock at Seeking Alpha.That is an increase of 297.20% in revenues from the year-ago report and is 79.93% lower than consensus estimates set at $16.3 million. The stock is down 29.89% to $7.03 after the report. The firm's higher revenue growth to earnings signals that the firm has not been able to reduce costs and has seen its profit margin decrease.Cara Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CARA updated stock price target summary.Find the latest Cara Therapeutics, Inc. (CARA) stock quote, history, news and other vital information to help you with your stock trading and investing.According to our current CARA stock forecast, the value of CARA Therapeutics shares will drop by -19.87% and reach $ 0.746314 per share by December 3, 2023. According to our technical indicators, the current sentiment is Bearish while the Fear & Greed Index is showing 39 (Fear).CARA stock recorded 12/30 (40%) green days with 12.33% price …Find out the direct holders, institutional holders and mutual fund holders for Cara Therapeutics, Inc. (CARA).1. Rumus Safety Stock Dasar. Opsi paling sederhana adalah mengadopsi formula persediaan cadangan yang banyak digunakan, yaitu: Safety stock = (penjualan maksimal harian x lead time maksimum) – (penjualan harian rata-rata x lead time rata-rata) Berikut adalah variabel yang masuk ke rumus ini:

22 thg 3, 2023 ... Cara Therapeutics Inc Stock Price: Bottom Line. As of March 22, 2023, Cara Therapeutics Inc's stock price is $5.18, which is down 5.65% from its ...In particular, the company currently has about $167 million in cash and marketable securities, and total liabilities are sitting around $19.5 million. Since the company suffered a loss of ~$88 ...Cara Therapeutics Inc’s ( CARA) price is currently down 36.91% so far this month. During the month of March, Cara Therapeutics Inc’s stock price has reached a high of $10.39 and a low of $6.11. Over the last year, Cara Therapeutics Inc has hit prices as high as $13.97 and as low as $6.58. Year to date, Cara Therapeutics Inc’s stock is ...That is an increase of 297.20% in revenues from the year-ago report and is 79.93% lower than consensus estimates set at $16.3 million. The stock is down 29.89% to $7.03 after the report. The firm's higher revenue growth to earnings signals that the firm has not been able to reduce costs and has seen its profit margin decrease.13 Nov 2023. Forward dividend & yield. N/A (N/A) Ex-dividend date. N/A. 1y target est. 10.29. Press Releases. Find the latest Cara Therapeutics, Inc. (CARA) stock quote, history, news and other vital information to help you with your stock trading and investing.Mar 22, 2023 · Cara Therapeutics Inc’s ( CARA) price is currently down 49.02% so far this month. During the month of March, Cara Therapeutics Inc’s stock price has reached a high of $10.39 and a low of $5.17. Over the last year, Cara Therapeutics Inc has hit prices as high as $13.97 and as low as $5.24. Year to date, Cara Therapeutics Inc’s stock is ... Cara Therapeutics (CARA) Company Description. Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic ...

Cara Therapeutics Inc (CARA) stock has fallen -6.06% while the S&P 500 has risen 0.34% as of 12:40 PM on Tuesday, Nov 7. CARA has fallen -$0.08 from the previous closing price of $1.33 on volume of 223,033 shares. Over the past year the S&P 500 has gained 15.08% while CARA has fallen -86.62%. CARA lost -$2.07 per share the …

Get the latest Cara Therapeutics, Inc. (CARA) stock news and headlines to help you in your trading and investing decisions.What's Happening with CARA Stock Today Cara Therapeutics Inc (CARA) stock has gained 5.52% while the S&P 500 has gained 0.24% as of 12:13 PM on Wednesday, Sep 13. CARA has gained $0.10 from the previous closing price of $1.72 on volume of 537,920 shares. Over the past year the S&P 500 has risen 13.73% while CARA is lower by -82.48%.7 ngày trước ... Getty Images Carastock. Light therapy is a gold-standard treatment that has been trusted by derms and celebrities for decades. It was once ...The above table shows the PS ratio for CARA vs its peers. Here we also display the market cap and forecasted growth for additional consideration. Price-To-Sales vs Peers: CARA is good value based on its Price-To-Sales Ratio (2.8x) compared to the peer average (7.9x).Analyst Forecast. According to 8 analysts, the average rating for CARA stock is "Strong Buy." The 12-month stock price forecast is $15.13, which is an increase of 1,472.28% from the latest price.Mar 21, 2023 · Cara Therapeutics Inc (CARA) stock is trading at $5.51 as of 3:36 PM on Tuesday, Mar 21, a gain of $0.21, or 3.96% from the previous closing price of $5.30. The stock has traded between $5.31 and $5.53 so far today. Volume today is below average. Cara Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in the discovery, development, and commercialization of novel therapeutics to treat serious medical conditions, including pruritus.A high-level overview of Cara Therapeutics, Inc. (CARA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and …The standard deviation of Shamrock Corp, stock is 16 percent. The standard deviation of Cara Co. stock is 12 percent, The covariance between these two stocks is 72. What is the correlation between Shamrock. and Cara stock? Round your answer to four decimal places.Cara Therapeutics, Inc. ( NASDAQ:CARA ) shareholders will have a reason to smile today, with the analysts making... Find the latest Cara Therapeutics, Inc. (CARA) stock quote, history, news and other vital information to help you with your stock trading and investing.

Cara Therapeutics Inc (CARA) stock is trading at $5.51 as of 3:36 PM on Tuesday, Mar 21, a gain of $0.21, or 3.96% from the previous closing price of $5.30. The stock has traded between $5.31 and $5.53 so far today. Volume today is below average. So far 335,181 shares have traded compared to average volume of 810,787 shares.

According to the issued ratings of 6 analysts in the last year, the consensus rating for Cara Therapeutics stock is Moderate Buy based on the current 1 sell rating, 1 hold rating and 4 buy ratings for CARA. The average twelve-month price prediction for Cara Therapeutics is $15.86 with a high price target of $25.00 and a low price target of $4.00.

In particular, the company currently has about $167 million in cash and marketable securities, and total liabilities are sitting around $19.5 million. Since the company suffered a loss of ~$88 ...218.25%. Free cash flow. Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. -8.64M. 47.45%. Get the latest Cara …Cara Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in the discovery, development, and commercialization of novel therapeutics to treat serious medical conditions, including pruritus.Cara Therapeutics Inc (CARA) stock has fallen -6.06% while the S&P 500 has risen 0.34% as of 12:40 PM on Tuesday, Nov 7. CARA has fallen -$0.08 from the previous closing price of $1.33 on volume of 223,033 shares. Over the past year the S&P 500 has gained 15.08% while CARA has fallen -86.62%. CARA lost -$2.07 per share the over the last 12 months.Aug 24, 2021 · CARA stock was up 2.8% as of Tuesday afternoon. On the date of publication, Nick Clarkson did not have (either directly or indirectly) any positions in the securities mentioned in this article. In this Motley Fool Live video recorded on Aug. 25, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss whether or not Cara stock is a buy after the big news. When our award ...Real time Cara Therapeutics (CARA) stock price quote, stock graph, news & analysis.Cara Therapeutics Announces Positive Topline Results CARA: Cara Therapeutics, Inc. 2022-06-30 07:00:00 Cara Therapeutics Announces Positive Topline Results from KOMFORT Phase 2 Trial of Oral Difelikefalin for the Treatment of Pruritus in Patients with Nostalgia Paresthetica CARA: Cara Therapeutics, Inc. 2022-06-30 07:00:00 Cara Therapeutics Announces Positive Topline Results from KOMFORT Phase ...

Aug 11, 2021 · The PEG ratio is a company's P/E ratio divided by the annual earnings growth rate and is typically around 1 for a fairly valued company. Working backward from a PEG ratio of 1, I forecasted a $51 ... Find out all the key statistics for Cara Therapeutics, Inc. (CARA), including valuation measures, fiscal year financial statistics, trading record, share statistics and more.Research Reports. SEC Filings. Insider Monkey. Get the latest Cara Therapeutics, Inc. (CARA) stock news and headlines to help you in your trading and investing decisions.Instagram:https://instagram. appl dividend historyixus etfcopart.com auctionsunnova energy stock According to 8 stock analysts, the average 12-month stock price forecast for CARA stock stock is $15.13, which predicts an increase of 1,327.36%. The lowest target is $1.00 and the highest is $28. On average, analysts rate CARA stock stock as a strong buy.Stock opname adalah aktivitas perhitungan jumlah stok barang atau produk yang menumpuk di gudang atau di toko sebelum barang tersebut. Yuk baca detailnya! alibaba lululemonirns When is Cara Therapeutics's earnings date? Cara Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 4th, 2024 based off last year's report dates. Learn more on CARA's earnings history.CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs). Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to ... what is the 5 year treasury rate Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the following day. After Hours trades will be posted from 4:15 p ...Post #2,000. Item 8.01 Other Information. As previously disclosed, on August 23, 2021, Cara Therapeutics, Inc. (“Cara”) received approval of its New Drug Application for KORSUVA™ injection for the treatment of moderate-to-severe pruritus in hemodialysis patients from the U.S. Food and Drug Administration (the “Approval Milestone”).